Drug Identity
Active Ingredient
Empagliflozin
Drug Class
Blood Glucose Lowering Drugs, Excluding Insulin
ATC Code
A10BK03
Status
Essential Medicine
How to Take It
Dosage information not available for this product.
Safety Alerts
Diabetic ketoacidosis, severe hepatic impairment, severe renal impairment, acute conditions predisposing to renal impairment, acute metabolic acidosis or pre-coma, cardiac or respiratory failure, recent MI, alcoholism, pregnancy, lactation, and elderly (above 75yrs)
Important Warnings
Congestive heart failure and cardiovascular disease, hepatic impairment, renal impairment, complicated urinary tract infections
consider temporarily interrupting treatment
Avoid initiation if eGFR below 60 ml/minute/1
Avoid if eGFR is persistently below 45 ml/minute/1
Monitor renal function before starting treatment and regularly during treatment
Monitor electrolyte balance and ensure adequate hydration
Correct hypovolaemia before starting treatment
Consider interrupting treatment if volume depletion occurs, concomitant antihypertensive therapy or use of diuretics
Side Effects
Genital infectionhypoglycaemia (in combination with insulin or sulfonylurea)polyuriapruritusurinary tract infectiondysuriavolume depletion (rare). Reports of altered LFTshepatitisGI upsettaste disturbanceskin reactionsreduced B12 absorptionsabnormal liver function testsrarely lactic acidosis
Drug Interactions
Diuretics
antihypertensive
UGT enzyme inducers
agents affecting renal functions
Alcohol
iodinated contrast agents
diuretics
corticosteroids
Pregnancy & Lactation
Pregnancy
Advised to avoid
Lactation
Advised to avoid
Price Intelligence
Rs 578.33
DRAP approved maximum price · per pack of 14 · approved 24 Sep, 2025
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
No retail prices recorded
Should you consider an alternative?
Other options containing Empagliflozin, and what they are not.
Identical active ingredient at the same strength. Cheapest per unit first.
Emjardm
5mg
Rs 180.5
SANOFI-AVENTIS
Adrance -M
5mg
Rs 237.44
Below approved ceilingATCO LABORATORIES LIMITED
Diampa-M
5mg
Rs 425
Getz Pharma (Pvt.) Ltd.
Xenglumet
5mg
Rs 441.7
HILTON
Elzanor
5mg
Rs 534
TABROS
Empozin-M
5mg
Rs 1,703.83 ceiling
Macter International Limited
Empaphage-M
5mg
Rs 159.11
Below approved ceilingNo DRAP alertsMartin Dow Marker Limited
Voreta Plus
5mg
Rs 1,411.01 ceiling
No DRAP alertsWilson's Pharmaceuticals
Glempa-M
5mg
Rs 560.83 ceiling
NABIQASIM INDUSTRIES (PVT) LTD.
SciAmpa-M
5mg
Rs 1,018.05 ceiling
No DRAP alertsScilife Pharma Private Limited
Empator-M
5mg
Rs 279.71 ceiling
No DRAP alertsMartin Dow Limited
Ordered by lowest price per unit where a pack size is known, then by price. Order is never affected by sponsorship. Not medical advice — confirm any change with your pharmacist or doctor.
For pharma professionalsCompany, market and opportunity intelligence
Company
372
brands
306
molecules
1
alerts